Drug for treating blepharospasm

Abstract

The invention belongs to the technical field of medicine and relates to a drug for treating blepharospasm to solve the problem of treating blepharospasm. The drug for treating blepharospasm is characterized by being prepared from, by mass, 10 parts of gypsum rubrum, 10 parts of Chinese taxillus herb, 12 parts of ginseng, 12 parts of fructus gardeniae, 15 parts of smoked plums, 12 parts of dried radix rehmanniae, 10 parts of semen cuscutae, 3 parts of pearl powder, 12 parts of radix scrophulariae, 10 parts of cortex moutan, 10 parts of rhizoma alismatis, 10 parts of radix angelicae pubescentis, 9 parts of radix ophiopogonis and 9 parts of cortex acanthopanacis.

Description

technical field [0001] The invention relates to a medicine for treating blepharospasm, in particular to a medicine combined with various traditional Chinese medicines, and belongs to the technical field of medicine. Background technique [0002] Blepharospasm is an unexplained, involuntary spasm and twitch of the muscles in the innervated area of ​​the facial nerve. It mostly occurs in middle-aged and elderly people. beautiful. [0003] Blepharospasm is the involuntary closing of the eyelids due to spasmodic contraction of the orbicularis oculi muscle. Often bilateral lesions, showing progressive progression. 2 / 3 are women, and most of them are over 60 years old. Its cause is unknown. Occasionally, patients with brainstem lesions. The frequency and time of spasms vary, and severe cases can cause functional blindness in patients. Symptoms stabilize in most patients within 3 to 5 years. 1 / 3 of the patients have related movement abnormalities, such as: Meige syndrome, ...

AI Technical Summary

Problems solved by technology

[0002] Blepharospasm is an unexplained, involuntary spasm and twitch of the muscles in the innervated area of ​​the facial nerve. It mostly occurs in middle-aged and elderly people. beautiful